To investigate the mechanisms underlying RNF38-driven inhibition in NPC, the NF-κB pathway and MAPK pathway were further examined, which were proven to be the major altered signaling pathways in NPC [37, 38]. The gene discussed is RNF38; the disease is nasopharyngeal carcinoma.